(Q34542897)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14584059%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

review article

1 reference

title

Cancer-related fatigue: evolving concepts in evaluation and treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14584059%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14584059%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Roberto Stasi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14584059%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Luca Abriani

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14584059%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Patrizia Beccaglia

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14584059%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Edmondo Terzoli

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14584059%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

language of work or name

English

0 references

publication date

1 November 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14584059%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14584059%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14584059%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14584059%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

1786-1801

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14584059%20AND%20SRC:MED&resulttype=core&format=json

The neuroendocrinology of depression and chronic stress

20 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

Fatigue and radiotherapy: (B) experience in patients 9 months following treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

Depression in patients with cancer. Diagnosis, biology, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

Double-blind, placebo-controlled, randomized phase III trial of darbepoetin alfa in lung cancer patients receiving chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

A qualitative study to explore the concept of fatigue/tiredness in cancer patients and in healthy individuals.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Fatigue and quality of life: lessons from the real world

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Fatigue in patients with breast cancer receiving adjuvant chemotherapy: a review of the literature

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Fatigue associated with cancer and its treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Pain in ovarian cancer patients. Prevalence, characteristics, and associated symptoms

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Fatigue in ovarian carcinoma patients: a neglected issue?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

The biologic basis of fatigue

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Mouse running activity is lowered by Brucella abortus treatment: a potential model to study chronic fatigue

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Energy expenditure in malnourished cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Cancer cachexia and protein metabolism

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Protein synthesis in muscle measured in vivo in cachectic patients with cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Increased resting energy expenditure and weight loss are related to a systemic inflammatory response in lung cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

The relationship between weight loss and interleukin 6 in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Weight loss and low body cell mass in males with lung cancer: relationship with systemic inflammation, acute-phase response, resting energy expenditure, and catabolic and anabolic hormones

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Do the differences between the amino acid compositions of acute-phase and muscle proteins have a bearing on nitrogen loss in traumatic states?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Muscle wasting associated with cancer cachexia is linked to an important activation of the atp-dependent ubiquitin-mediated proteolysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Tumour necrosis factor in man: clinical and biological observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Lectin-gold labeling of glycoconjugates in normal and Brattleboro rat papilla: effect of vasopressin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Tumor necrosis factor and the acute metabolic response to tissue injury in man

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Interleukin-1-induced anorexia in the rat. Influence of prostaglandins

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Acute-phase response of human hepatocytes: Regulation of acute-phase protein synthesis by interleukin-6

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Effects of human recombinant interleukin-1β on protein synthesis in rat tissues compared with a classical acute-phase reaction induced by turpentine. Rapid response of muscle to interleukin-1β

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Elevated circulating interleukin-6 is associated with an acute-phase response but reduced fixed hepatic protein synthesis in patients with cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Eicosanoids, thermogenesis and thermoregulation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Indomethacin blocks the anorexic action of interleukin-1.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Signalling pathways regulating protein turnover in skeletal muscle

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Characterization of a cancer cachectic factor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Activation of ATP-ubiquitin-dependent proteolysis in skeletal muscle in vivo and murine myoblasts in vitro by a proteolysis-inducing factor (PIF)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Proteolysis-inducing factor regulates hepatic gene expression via the transcription factors NF-(kappa)B and STAT3.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Proteolysis-inducing factor is expressed in tumours of patients with gastrointestinal cancers and correlates with weight loss

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Recent advances in the understanding of skeletal muscle fatigue.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Protective and damaging effects of stress mediators: the good and bad sides of the response to stress

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Fatigue in patients with cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Fatigue in patients with prostate cancer receiving hormone therapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Fatigue in cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Radiotherapy-related fatigue

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Psychosocial problems among survivors of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Mechanisms and management of toxicities associated with high-dose interferon alfa-2b therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Fatigue and psychiatric morbidity among Hodgkin's disease survivors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Depression in patients with lung cancer: prevalence and risk factors derived from quality-of-life data

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Fatigue, depression and quality of life in cancer patients: how are they related?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Stress, depression and the activation of the immune system

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

The Colorado thyroid disease prevalence study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Epidemiology and prevention of clinical and subclinical hypothyroidism

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Hypothyroidism: a frequent event after radiotherapy and after radiotherapy with chemotherapy for patients with head and neck carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Late medical complications and fatigue in Hodgkin's disease survivors.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Epoetin treatment of anemia associated with cancer therapy: a systematic review and meta-analysis of controlled clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Association between asthenia and nutritional status, lean body mass, anemia, psychological status, and tumor mass in patients with advanced breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Asthenia: an important symptom in cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Development and validation of the cancer fatigue scale: a brief, three-dimensional, self-rating scale for assessment of fatigue in cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

The measurement of fatigue: A new instrument

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

The multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Measuring quality of life in chronic illness: the functional assessment of chronic illness therapy measurement system

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Fatigue in cancer patients compared with fatigue in the general United States population.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Comparison of two quality-of-life instruments for cancer patients: the functional assessment of cancer therapy-general and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Erythropoietin for anaemia in cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Erythropoietin reduces anemia and transfusions after chemotherapy with paclitaxel and carboplatin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Epoetin alfa therapy increases hemoglobin levels and improves quality of life in patients with cancer-related anemia who are not receiving chemotherapy and patients with anemia who are receiving chemotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia of chronic disease associated with cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

A dose-finding and safety study of novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia in patients receiving multicycle chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Randomized, dose-finding study of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Daily fatigue patterns and effect of exercise in women with breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Exercise reduces daily fatigue in women with breast cancer receiving chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Fatigue and quality of life outcomes of exercise during cancer treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021

Interferon-induced fatigue in patients with melanoma: a pilot study of exercise and methylphenidate

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11742

7 January 2021